What is the appropriate workup for an adult patient, possibly of Northern European descent, with a transferrin saturation (TSAT) level of 70, suggesting iron overload, and potential risk factors for hemochromatosis or frequent blood transfusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Transferrin Saturation of 70%

A TSAT of 70% is pathognomonic for primary iron overload and requires immediate HFE genetic testing for C282Y and H63D mutations, followed by hepatic MRI if genetic testing is negative or inconclusive. 1, 2

Immediate Diagnostic Steps

1. Confirm Iron Overload Pattern

  • Obtain serum ferritin immediately to complete the iron panel, as TSAT ≥45% combined with elevated ferritin creates the diagnostic pattern for hereditary hemochromatosis 3, 1
  • A TSAT of 70% with elevated ferritin (>200 μg/L in females, >300 μg/L in males) confirms biochemical iron overload requiring genetic evaluation 1, 4
  • Check complete blood count with reticulocytes to exclude anemia and red cell disorders that could cause secondary iron overload 3

2. Order HFE Genetic Testing

  • Test for C282Y and H63D mutations immediately without delay, as this is the most cost-effective approach and C282Y homozygosity accounts for 85-90% of hereditary hemochromatosis cases 1, 4
  • For patients of Northern European descent, HFE testing has the highest pre-test probability and should be performed first 3
  • Do not wait for additional testing before ordering genetics, as early diagnosis prevents irreversible organ damage 1

3. If HFE Testing is Negative or Shows Only Heterozygosity

  • Proceed to hepatic MRI with R2 quantification* to confirm tissue iron overload and guide further genetic testing for non-HFE hemochromatosis genes 1, 2, 5
  • MRI can differentiate primary hemochromatosis (predominant hepatic iron with minimal splenic involvement) from secondary causes (increased splenic iron) 2
  • Low spleen iron (R2* <50 s⁻¹) is significantly associated with genetic mutations in hemochromatosis genes 5
  • Consider next-generation sequencing of non-HFE genes (HJV, TFR2, CP, SLC40A1) only after confirming true iron overload by MRI AND excluding secondary causes 3, 2

Assess for Organ Damage and Advanced Disease

Liver Assessment

  • Check liver enzymes (ALT, AST) and platelet count immediately, as ferritin >1,000 μg/L with elevated transaminases and platelets <200 predicts cirrhosis in 80% of cases 3, 1, 4
  • Patients with ferritin <1,000 μg/L, normal transaminases, and no hepatomegaly have very low risk of advanced liver fibrosis 3
  • Consider liver biopsy or elastography if ferritin >1,000 μg/L, elevated liver enzymes, hepatomegaly, age >40 years, or platelet count <200 to assess for cirrhosis 1, 4

Cardiac Evaluation

  • Obtain ECG and echocardiography to screen for arrhythmia and cardiac dysfunction in patients with severe iron overload 3
  • If signs or symptoms of heart disease are present (conduction abnormalities or contractile dysfunction), proceed to cardiac MRI for myocardial iron quantification without delaying treatment 3

Endocrine and Metabolic Screening

  • Screen for diabetes mellitus, as this is a common manifestation of hemochromatosis and unstable diabetes with elevated ferritin has an odds ratio of 40.1 for undiagnosed hemochromatosis 3, 6
  • Assess thyroid and gonadal function, as these endocrine organs are commonly affected 1

Musculoskeletal Assessment

  • Evaluate for arthropathy, particularly affecting the 2nd and 3rd metacarpophalangeal joints, ankles, hips, and wrists, as 86.5% of hemochromatosis patients report arthritis or joint pain 3
  • Consider screening for osteoporosis, as this is common and does not respond uniformly to phlebotomy 3

Exclude Secondary Causes Before Attributing to Genetic Hemochromatosis

Systematically evaluate for secondary causes of elevated TSAT before concluding this is genetic hemochromatosis, particularly if HFE testing is negative 2:

  • Assess for metabolic syndrome components (obesity, diabetes, dyslipidemia, hypertension), as these commonly contribute to hepatic iron accumulation 2
  • Obtain detailed alcohol consumption history, as excessive alcohol elevates TSAT and increases risk of fibrosis when combined with iron overload 2
  • Exclude chronic liver disease from other causes (viral hepatitis, NAFLD), as these can elevate ferritin independent of true iron overload 2, 4
  • Rule out hematologic disorders causing ineffective erythropoiesis (thalassemia, sideroblastic anemia) 3, 7
  • Consider inflammatory conditions and malignancy, as ferritin can be falsely elevated by inflammation, cell necrosis, and chronic disease 2, 4

Family Screening

  • Screen all first-degree relatives with TSAT and ferritin, followed by HFE genetic testing if abnormal, as this is a heritable condition with high penetrance in C282Y homozygotes 1, 4
  • Perform both phenotypic screening (iron studies) and genotypic testing simultaneously in relatives of confirmed cases 4

Critical Pitfalls to Avoid

  • Never diagnose hemochromatosis based on genotype alone—diagnosis requires both genetic findings AND phenotypic evidence of iron overload 2
  • Do not assume elevated ferritin equals iron overload, as ferritin can be falsely elevated by inflammation, liver disease, malignancy, and chronic inflammatory conditions 2, 4
  • Do not delay genetic testing while pursuing other investigations—HFE testing should be ordered immediately when TSAT is ≥45% 1, 4
  • Avoid relying on a single test—always obtain both TSAT and ferritin together for optimal diagnostic accuracy 4
  • A TSAT of 70% is far above the diagnostic threshold of 45% and represents severe iron dysregulation requiring urgent evaluation 3, 1

References

Guideline

Diagnosis and Management of Hereditary Hemochromatosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated Iron Parameters with Negative HFE Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Genetic Testing for Elevated Iron Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.

Critical reviews in clinical laboratory sciences, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.